Position in JNJ
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$14,806,859,626
-$616,410,691 QoQ
Shares Held
58,301,609
-7.6% QoQ
Ownership
2.42%
of shares outstanding
% of Portfolio
1.03%
of 13F equity value
Holder Rank
#6
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 79%
Shared 1%
None 21%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $61,093,076,744 across 19 Drug Manufacturers - General names. JNJ ranks #2 (24.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
12,598,524 | $15,111,048,894 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
58,301,609 | $14,806,859,626 | |
| 3 | ABBV |
AbbVie Inc.
|
47,862,796 | $12,044,193,975 | |
| 4 | MRK |
Merck & Co., Inc.
|
43,886,420 | $5,639,404,964 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
71,713,442 | $4,132,128,518 | |
| 6 | AZN |
Astrazeneca PLC
|
19,204,823 | $3,641,618,528 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
20,820,621 | $2,630,477,247 | |
| 8 | AMGN |
Amgen Inc
|
3,588,484 | $1,299,461,817 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,806,859,626 | 58,301,609 | Shares | Other | 2026-08-12 | |
| 2026-03-31 | $15,423,270,317 | 63,096,344 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $12,118,627,346 | 58,558,238 | Shares | Other | 2026-02-11 | |
| 2025-09-30 | $10,873,187,509 | 58,640,856 | Shares | Other | 2025-11-07 | |
| 2025-06-30 | $8,569,651,672 | 56,102,466 | Shares | Other | 2025-08-12 | |
| 2025-03-31 | $8,965,615,866 | 54,061,842 | Shares | Other | 2025-05-12 | |
| 2024-12-31 | $5,609,004,112 | 38,784,429 | Shares | Other | 2025-02-12 | |
| 2024-09-30 | $5,568,058,116 | 34,358,004 | Shares | Sole | 2024-12-26 | |
| 2024-06-30 | $4,360,586,977 | 29,834,339 | Shares | Other | 2024-12-26 | |
| 2024-03-31 | $4,779,262,371 | 30,212,165 | Shares | Other | 2024-12-26 | |
| 2023-12-31 | $4,686,966,114 | 29,902,808 | Shares | Other | 2024-12-26 | |
| 2023-09-30 | $4,891,828,232 | 31,408,207 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $5,260,571,692 | 31,782,091 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $3,987,144,980 | 25,723,516 | Shares | Sole | 2023-05-18 | |
| 2022-12-31 | $5,593,176,553 | 31,662,477 | Shares | Other | 2023-02-13 | |
| 2022-09-30 | $4,922,377,725 | 30,132,087 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $5,398,510,085 | 30,412,428 | Shares | Other | 2022-08-11 | |
| 2022-03-31 | $4,591,653,210 | 25,907,878 | Shares | Other | 2022-05-11 | |
| 2021-12-31 | $4,906,493,730 | 28,681,205 | Shares | Other | 2022-02-11 | |
| 2021-09-30 | $4,337,442,478 | 26,857,229 | Shares | Other | 2021-11-12 | |
| 2021-06-30 | $4,225,054,484 | 25,646,804 | Shares | Other | 2021-08-12 | |
| 2021-03-31 | $4,241,675,614 | 25,808,796 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $3,849,034,783 | 24,456,950 | Shares | Other | 2021-02-19 | |
| 2020-09-30 | $3,506,936,133 | 23,555,455 | Shares | Other | 2020-11-12 | |
| 2020-06-30 | $3,260,204,748 | 23,182,854 | Shares | Other | 2020-08-11 | |
| 2020-03-31 | $3,025,788,158 | 23,074,721 | Shares | Other | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||